Exact Mass: 550.2391495999999
Exact Mass Matches: 550.2391495999999
Found 500 metabolites which its exact mass value is equals to given mass value 550.2391495999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Eucommin A
Manumycin A
C31H38N2O7 (550.2678877999999)
A polyketide with formula C31H38N2O7 initially isolated from Streptomyces parvulus as a result of a random screening program for farnesyl transferase (FTase) inhibitors. It is a natural product that exhibits anticancer and antibiotic properties. Manumycin A is a polyketide with formula C31H38N2O7 initially isolated from Streptomyces parvulus as a result of a random screening program for farnesyl transferase (FTase) inhibitors. It is a natural product that exhibits anticancer and antibiotic properties. It has a role as an EC 1.8.1.9 (thioredoxin reductase) inhibitor, an EC 2.5.1.58 (protein farnesyltransferase) inhibitor, an antineoplastic agent, an apoptosis inducer, an antimicrobial agent, a bacterial metabolite, an antiatherosclerotic agent and a marine metabolite. It is a polyketide, an enamide, an epoxide, an organic heterobicyclic compound, a secondary carboxamide and a tertiary alcohol. Manumycin A is a natural product found in Streptomyces, Streptomyces griseoaurantiacus, and Streptomyces parvulus D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
Lappaol B
Tracheloside
Constituent of Carthamus tinctorius (safflower). Tracheloside is found in safflower, fats and oils, and herbs and spices. Tracheloside is found in fats and oils. Tracheloside is a constituent of Carthamus tinctorius (safflower) Tracheloside is an antiestrogenic lignin. Tracheloside promotes keratinocyte proliferation through ERK1/2 stimulation. Tracheloside is a good candidate to promote wound healing[1]. Tracheloside is an antiestrogenic lignin. Tracheloside promotes keratinocyte proliferation through ERK1/2 stimulation. Tracheloside is a good candidate to promote wound healing[1].
Scorzonoside
Constituent of Scorzonera hispanica (scorzonera). Scorzonoside is found in coffee and coffee products and root vegetables. Scorzonoside is found in coffee and coffee products. Scorzonoside is a constituent of Scorzonera hispanica (scorzonera).
Manumycin A
C31H38N2O7 (550.2678877999999)
Fantofarone
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
PA(2:0/PGF2alpha)
C25H43O11P (550.2542857999999)
PA(2:0/PGF2alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGF2alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin F2alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGF2alpha/2:0)
C25H43O11P (550.2542857999999)
PA(PGF2alpha/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF2alpha/2:0), in particular, consists of one chain of one Prostaglandin F2alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/PGE1)
C25H43O11P (550.2542857999999)
PA(2:0/PGE1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGE1), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin E1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGE1/2:0)
C25H43O11P (550.2542857999999)
PA(PGE1/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE1/2:0), in particular, consists of one chain of one Prostaglandin E1 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/PGD1)
C25H43O11P (550.2542857999999)
PA(2:0/PGD1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGD1), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin D1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGD1/2:0)
C25H43O11P (550.2542857999999)
PA(PGD1/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD1/2:0), in particular, consists of one chain of one Prostaglandin D1 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Lappaol B
Lappaol b is a member of the class of compounds known as 2-arylbenzofuran flavonoids. 2-arylbenzofuran flavonoids are phenylpropanoids containing the 2-phenylbenzofuran moiety. Lappaol b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lappaol b can be found in burdock, which makes lappaol b a potential biomarker for the consumption of this food product.
2-Hydroxyarctiin
2-hydroxyarctiin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 2-hydroxyarctiin can be found in safflower, which makes 2-hydroxyarctiin a potential biomarker for the consumption of this food product.
Tracheloside
Tracheloside is a glycoside and a lignan. It has a role as a metabolite. Tracheloside is a natural product found in Carthamus oxyacanthus, Trachelospermum asiaticum, and other organisms with data available. A natural product found particularly in Carthamus tinctorius and Trachelospermum. Tracheloside is an antiestrogenic lignin. Tracheloside promotes keratinocyte proliferation through ERK1/2 stimulation. Tracheloside is a good candidate to promote wound healing[1]. Tracheloside is an antiestrogenic lignin. Tracheloside promotes keratinocyte proliferation through ERK1/2 stimulation. Tracheloside is a good candidate to promote wound healing[1].
Mortonol B
pseudolaric acid A O-beta-d-glucopyranoside
Pseudolaric acid A-O-β-D-glucopyranoside, isolated from Cortex Pseudolaricis, demonstrates antifungal and antifertility activities[1]. Pseudolaric acid A-O-β-D-glucopyranoside, isolated from Cortex Pseudolaricis, demonstrates antifungal and antifertility activities[1].
(1R*,2R*,3S*,5Z,7S*,8S*,9S*,10S*,11R*,12S*,14S*,17R*)-2,3,14-triacetoxy-8,9,11,12-bisepoxy-17-hydroxybriar-5-en-18-one
4-[beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranosyloxy]-3-(methoxyphenyl)propiophenone
(2E)-1-{2,4-dihydroxy-3-[(1R,2E,5R)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenyl-2-hepten-1-yl]-6-methoxyphenyl}-3-phenyl-2-propen-1-one|Alpinnanin B|ent-alpinnanin B
michaolide J
A cembrane diterpenoid with cytotoxic activity isolated from the soft coral Lobophytum michaelae.
3,3,5-trimethoxy-4,7-epoxy-8,5-neolign-7-ene-4,9,9-triol 9-beta-D-glucopyranoside|[2-(4-hydroxy-3,5-dimethoxyphenyl)-5-(3-hydroxypropyl)-7-methoxybenzofuran-3-yl]methyl beta-D-glucopyranoside
(1R,3aS,4Z,8S,8aR,9S,12aS,13S,13aR)-8,9,13-tris(acetyloxy)-5-[(acetyloxy)methyl]-3a,6,7,8,8a,9,10,11,12,12a,13,13a-dodecahydro-13a-hydroxy-1,8a-dimethyl-12-methylidenebenzo[4,5]cyclodeca[1,2-b]furan-2(1H)-one|junceellonoid B
(3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol
4-acetate-1,2,3,5-tetrakis(2-methyl-2-butenoate)inositol
3-acetate-1,2,4,5-tetrakis(2-methyl-2-butenoate)inositol
7beta,9,10beta,20-tetracetoxy-13beta,17-epoxy-3,8-secotaxa-3E,8E,11-triene-2alpha,5alpha-diol|canataxpyran A
1-O-cinnamoyl-17-defurano-17-oxosalannicacid methyl ester|17-defurano-17-oxoohchinin
(5R,6R,8S,9R,10S,12S)-15,16-epoxy-2-oxo-6-O-(beta-D-glucopyranosyl)-cleroda-3,13(16),14-trien-17,12-olid-18-oic acid methyl ester
3-O-angeloyl-17-(benzoyloxy)ingenol|ingenol-3-angelate-17-benzoate
5-methoxy-(E)-resveratrol 3-O-rutinoside|trans-4,5-dihydroxy-3-methoxystilbene-5-O-[alpha-L-rhamnopyranosyl-(1->6)]-beta-D-glucopyranoside
1, 1-[[2, 4-Bis(6-methoxy-1, 3-benzodioxol-5-yl)-1, 3-cyclobutanediyl]dicarbonyl]bispyrrolidine, 9CI
C30H34N2O8 (550.2315044000001)
15-hydroxysolanascone-beta-glucopyranoside tetraacetate
(1R*,3aS*,4Z,8S*,8aS*,9S*,11R*,12aS*,13S*,13aS*)-1,2,3a,6,7,8,8a,9,10,11,12,12a,13,13a-tetradecahydro-13a-hydroxy-1,5,8a-trimethyl-12-methylidene-2-oxobenzo[4,5]cyclodeca[1,2-b]furan-8,9,11,13-tetrayl tetraacetate|frajunolide A|rel-(1S,2S,5Z,7S,8S,9S,10S,12R,14S,17R)-2,9,12,14-tetraacetoxy-8-hydroxybriara-5,11(20)-dien-18,7-olide
PseudolaricacidAbeta-D-glucoside
PseudolaricacidAbeta-D-glucoside is a natural product found in Pseudolarix amabilis and Larix kaempferi with data available. Pseudolaric acid A-O-β-D-glucopyranoside, isolated from Cortex Pseudolaricis, demonstrates antifungal and antifertility activities[1]. Pseudolaric acid A-O-β-D-glucopyranoside, isolated from Cortex Pseudolaricis, demonstrates antifungal and antifertility activities[1].
Ala Phe Gln Trp
C28H34N6O6 (550.2539704000001)
Ala Phe Trp Gln
C28H34N6O6 (550.2539704000001)
Ala Gln Phe Trp
C28H34N6O6 (550.2539704000001)
Ala Gln Trp Phe
C28H34N6O6 (550.2539704000001)
Ala Trp Phe Gln
C28H34N6O6 (550.2539704000001)
Ala Trp Gln Phe
C28H34N6O6 (550.2539704000001)
Cys Asp Lys Trp
C24H34N6O7S (550.2209574000001)
Cys Asp Trp Lys
C24H34N6O7S (550.2209574000001)
Cys Lys Asp Trp
C24H34N6O7S (550.2209574000001)
Cys Lys Trp Asp
C24H34N6O7S (550.2209574000001)
Cys Arg Ser Trp
Cys Arg Trp Ser
Cys Ser Arg Trp
Cys Ser Trp Arg
Cys Trp Asp Lys
C24H34N6O7S (550.2209574000001)
Cys Trp Lys Asp
C24H34N6O7S (550.2209574000001)
Cys Trp Arg Ser
Cys Trp Ser Arg
Asp Cys Lys Trp
C24H34N6O7S (550.2209574000001)
Asp Cys Trp Lys
C24H34N6O7S (550.2209574000001)
Asp Phe Asn Arg
Asp Phe Arg Asn
Asp Lys Cys Trp
C24H34N6O7S (550.2209574000001)
Asp Lys Trp Cys
C24H34N6O7S (550.2209574000001)
Asp Asn Phe Arg
Asp Asn Arg Phe
Asp Arg Phe Asn
Asp Arg Asn Phe
Asp Trp Cys Lys
C24H34N6O7S (550.2209574000001)
Asp Trp Lys Cys
C24H34N6O7S (550.2209574000001)
Glu Glu His His
Glu Phe Gln Gln
Glu His Glu His
Glu His His Glu
Glu Gln Phe Gln
Glu Gln Gln Phe
Phe Ala Gln Trp
C28H34N6O6 (550.2539704000001)
Phe Ala Trp Gln
C28H34N6O6 (550.2539704000001)
Phe Asp Asn Arg
Phe Asp Arg Asn
Phe Glu Gln Gln
Phe Phe His Thr
C28H34N6O6 (550.2539704000001)
Phe Phe Thr His
C28H34N6O6 (550.2539704000001)
Phe His Phe Thr
C28H34N6O6 (550.2539704000001)
Phe His Thr Phe
C28H34N6O6 (550.2539704000001)
Phe Asn Asp Arg
Phe Asn Arg Asp
Phe Gln Ala Trp
C28H34N6O6 (550.2539704000001)
Phe Gln Glu Gln
Phe Gln Gln Glu
Phe Gln Trp Ala
C28H34N6O6 (550.2539704000001)
Phe Arg Asp Asn
Phe Arg Asn Asp
Phe Thr Phe His
C28H34N6O6 (550.2539704000001)
Phe Thr His Phe
C28H34N6O6 (550.2539704000001)
Phe Trp Ala Gln
C28H34N6O6 (550.2539704000001)
Phe Trp Gln Ala
C28H34N6O6 (550.2539704000001)
His Glu Glu His
His Glu His Glu
His Phe Phe Thr
C28H34N6O6 (550.2539704000001)
His Phe Thr Phe
C28H34N6O6 (550.2539704000001)
His His Glu Glu
His Met Thr Tyr
C24H34N6O7S (550.2209574000001)
His Met Tyr Thr
C24H34N6O7S (550.2209574000001)
His Thr Phe Phe
C28H34N6O6 (550.2539704000001)
His Thr Met Tyr
C24H34N6O7S (550.2209574000001)
His Thr Tyr Met
C24H34N6O7S (550.2209574000001)
His Tyr Met Thr
C24H34N6O7S (550.2209574000001)
His Tyr Thr Met
C24H34N6O7S (550.2209574000001)
Lys Cys Asp Trp
C24H34N6O7S (550.2209574000001)
Lys Cys Trp Asp
C24H34N6O7S (550.2209574000001)
Lys Asp Cys Trp
C24H34N6O7S (550.2209574000001)
Lys Asp Trp Cys
C24H34N6O7S (550.2209574000001)
Lys Met Ser Trp
C25H38N6O6S (550.2573408000001)
Lys Met Trp Ser
C25H38N6O6S (550.2573408000001)
Lys Ser Met Trp
C25H38N6O6S (550.2573408000001)
Lys Ser Trp Met
C25H38N6O6S (550.2573408000001)
Lys Trp Cys Asp
C24H34N6O7S (550.2209574000001)
Lys Trp Asp Cys
C24H34N6O7S (550.2209574000001)
Lys Trp Met Ser
C25H38N6O6S (550.2573408000001)
Lys Trp Ser Met
C25H38N6O6S (550.2573408000001)
Met His Thr Tyr
C24H34N6O7S (550.2209574000001)
Met His Tyr Thr
C24H34N6O7S (550.2209574000001)
Met Lys Ser Trp
C25H38N6O6S (550.2573408000001)
Met Lys Trp Ser
C25H38N6O6S (550.2573408000001)
Met Met Asn Arg
Met Met Arg Asn
Met Asn Met Arg
Met Asn Arg Met
Met Asn Thr Trp
C24H34N6O7S (550.2209574000001)
Met Asn Trp Thr
C24H34N6O7S (550.2209574000001)
Met Gln Ser Trp
C24H34N6O7S (550.2209574000001)
Met Gln Trp Ser
C24H34N6O7S (550.2209574000001)
Met Arg Met Asn
Met Arg Asn Met
Met Ser Lys Trp
C25H38N6O6S (550.2573408000001)
Met Ser Gln Trp
C24H34N6O7S (550.2209574000001)
Met Ser Trp Lys
C25H38N6O6S (550.2573408000001)
Met Ser Trp Gln
C24H34N6O7S (550.2209574000001)
Met Thr His Tyr
C24H34N6O7S (550.2209574000001)
Met Thr Asn Trp
C24H34N6O7S (550.2209574000001)
Met Thr Trp Asn
C24H34N6O7S (550.2209574000001)
Met Thr Tyr His
C24H34N6O7S (550.2209574000001)
Met Trp Lys Ser
C25H38N6O6S (550.2573408000001)
Met Trp Asn Thr
C24H34N6O7S (550.2209574000001)
Met Trp Gln Ser
C24H34N6O7S (550.2209574000001)
Met Trp Ser Lys
C25H38N6O6S (550.2573408000001)
Met Trp Ser Gln
C24H34N6O7S (550.2209574000001)
Met Trp Thr Asn
C24H34N6O7S (550.2209574000001)
Met Tyr His Thr
C24H34N6O7S (550.2209574000001)
Met Tyr Thr His
C24H34N6O7S (550.2209574000001)
Asn Asp Phe Arg
Asn Asp Arg Phe
Asn Phe Asp Arg
Asn Phe Arg Asp
Asn Met Met Arg
Asn Met Arg Met
Asn Met Thr Trp
C24H34N6O7S (550.2209574000001)
Asn Met Trp Thr
C24H34N6O7S (550.2209574000001)
Asn Arg Asp Phe
Asn Arg Phe Asp
Asn Arg Met Met
Asn Thr Met Trp
C24H34N6O7S (550.2209574000001)
Asn Thr Trp Met
C24H34N6O7S (550.2209574000001)
Asn Trp Met Thr
C24H34N6O7S (550.2209574000001)
Asn Trp Thr Met
C24H34N6O7S (550.2209574000001)
Gln Ala Phe Trp
C28H34N6O6 (550.2539704000001)
Gln Ala Trp Phe
C28H34N6O6 (550.2539704000001)
Gln Glu Phe Gln
Gln Glu Gln Phe
Gln Phe Ala Trp
C28H34N6O6 (550.2539704000001)
Gln Phe Glu Gln
Gln Phe Gln Glu
Gln Phe Trp Ala
C28H34N6O6 (550.2539704000001)
Gln Met Ser Trp
C24H34N6O7S (550.2209574000001)
Gln Met Trp Ser
C24H34N6O7S (550.2209574000001)
Gln Gln Glu Phe
Gln Gln Phe Glu
Gln Ser Met Trp
C24H34N6O7S (550.2209574000001)
Gln Ser Trp Met
C24H34N6O7S (550.2209574000001)
Gln Trp Ala Phe
C28H34N6O6 (550.2539704000001)
Gln Trp Phe Ala
C28H34N6O6 (550.2539704000001)
Gln Trp Met Ser
C24H34N6O7S (550.2209574000001)
Gln Trp Ser Met
C24H34N6O7S (550.2209574000001)
Arg Cys Ser Trp
Arg Cys Trp Ser
Arg Asp Phe Asn
Arg Asp Asn Phe
Arg Phe Asp Asn
Arg Phe Asn Asp
Arg Met Met Asn
Arg Met Asn Met
Arg Asn Asp Phe
Arg Asn Phe Asp
Arg Asn Met Met
Arg Ser Cys Trp
Arg Ser Trp Cys
Arg Trp Cys Ser
Arg Trp Ser Cys
Ser Cys Arg Trp
Ser Cys Trp Arg
Ser Lys Met Trp
C25H38N6O6S (550.2573408000001)
Ser Lys Trp Met
C25H38N6O6S (550.2573408000001)
Ser Met Lys Trp
C25H38N6O6S (550.2573408000001)
Ser Met Gln Trp
C24H34N6O7S (550.2209574000001)
Ser Met Trp Lys
C25H38N6O6S (550.2573408000001)
Ser Met Trp Gln
C24H34N6O7S (550.2209574000001)
Ser Gln Met Trp
C24H34N6O7S (550.2209574000001)
Ser Gln Trp Met
C24H34N6O7S (550.2209574000001)
Ser Arg Cys Trp
Ser Arg Trp Cys
Ser Trp Cys Arg
Ser Trp Lys Met
C25H38N6O6S (550.2573408000001)
Ser Trp Met Lys
C25H38N6O6S (550.2573408000001)
Ser Trp Met Gln
C24H34N6O7S (550.2209574000001)
Ser Trp Gln Met
C24H34N6O7S (550.2209574000001)
Ser Trp Arg Cys
Thr Phe Phe His
C28H34N6O6 (550.2539704000001)
Thr Phe His Phe
C28H34N6O6 (550.2539704000001)
Thr His Phe Phe
C28H34N6O6 (550.2539704000001)
Thr His Met Tyr
C24H34N6O7S (550.2209574000001)
Thr His Tyr Met
C24H34N6O7S (550.2209574000001)
Thr Met His Tyr
C24H34N6O7S (550.2209574000001)
Thr Met Asn Trp
C24H34N6O7S (550.2209574000001)
Thr Met Trp Asn
C24H34N6O7S (550.2209574000001)
Thr Met Tyr His
C24H34N6O7S (550.2209574000001)
Thr Asn Met Trp
C24H34N6O7S (550.2209574000001)
Thr Asn Trp Met
C24H34N6O7S (550.2209574000001)
Thr Trp Met Asn
C24H34N6O7S (550.2209574000001)
Thr Trp Asn Met
C24H34N6O7S (550.2209574000001)
Thr Tyr His Met
C24H34N6O7S (550.2209574000001)
Thr Tyr Met His
C24H34N6O7S (550.2209574000001)
Trp Ala Phe Gln
C28H34N6O6 (550.2539704000001)
Trp Ala Gln Phe
C28H34N6O6 (550.2539704000001)
Trp Cys Asp Lys
C24H34N6O7S (550.2209574000001)
Trp Cys Lys Asp
C24H34N6O7S (550.2209574000001)
Trp Cys Arg Ser
Trp Cys Ser Arg
Trp Asp Cys Lys
C24H34N6O7S (550.2209574000001)
Trp Asp Lys Cys
C24H34N6O7S (550.2209574000001)
Trp Phe Ala Gln
C28H34N6O6 (550.2539704000001)
Trp Phe Gln Ala
C28H34N6O6 (550.2539704000001)
Trp Lys Cys Asp
C24H34N6O7S (550.2209574000001)
Trp Lys Asp Cys
C24H34N6O7S (550.2209574000001)
Trp Lys Met Ser
C25H38N6O6S (550.2573408000001)
Trp Lys Ser Met
C25H38N6O6S (550.2573408000001)
Trp Met Lys Ser
C25H38N6O6S (550.2573408000001)
Trp Met Asn Thr
C24H34N6O7S (550.2209574000001)
Trp Met Gln Ser
C24H34N6O7S (550.2209574000001)
Trp Met Ser Lys
C25H38N6O6S (550.2573408000001)
Trp Met Ser Gln
C24H34N6O7S (550.2209574000001)
Trp Met Thr Asn
C24H34N6O7S (550.2209574000001)
Trp Asn Met Thr
C24H34N6O7S (550.2209574000001)
Trp Asn Thr Met
C24H34N6O7S (550.2209574000001)
Trp Gln Ala Phe
C28H34N6O6 (550.2539704000001)
Trp Gln Phe Ala
C28H34N6O6 (550.2539704000001)
Trp Gln Met Ser
C24H34N6O7S (550.2209574000001)
Trp Gln Ser Met
C24H34N6O7S (550.2209574000001)
Trp Arg Cys Ser
Trp Arg Ser Cys
Trp Ser Cys Arg
Trp Ser Lys Met
C25H38N6O6S (550.2573408000001)
Trp Ser Met Lys
C25H38N6O6S (550.2573408000001)
Trp Ser Met Gln
C24H34N6O7S (550.2209574000001)
Trp Ser Gln Met
C24H34N6O7S (550.2209574000001)
Trp Ser Arg Cys
Trp Thr Met Asn
C24H34N6O7S (550.2209574000001)
Trp Thr Asn Met
C24H34N6O7S (550.2209574000001)
Tyr His Met Thr
C24H34N6O7S (550.2209574000001)
Tyr His Thr Met
C24H34N6O7S (550.2209574000001)
Tyr Met His Thr
C24H34N6O7S (550.2209574000001)
Tyr Met Thr His
C24H34N6O7S (550.2209574000001)
Tyr Thr His Met
C24H34N6O7S (550.2209574000001)
Tyr Thr Met His
C24H34N6O7S (550.2209574000001)
Pluripotin
Scorzonoside
2-Methyl-2-propanyl 4-[1-(phenylsulfonyl)-3-(4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-1H-pyrazo le-1-carboxylate
9,9-Bis[4-(2-oxiranemethyloxyethyloxy)phenyl]fluorene
benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid
3-methoxy-6-(4-methoxyphenyl)-6-phenyl-Dibenzo[3,4:7,8]fluoreno[2,1-b]pyran-9(6H)-one
(11aR)-3,7-Bis(2,4,6-trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1,7-fg][1,3,2]dioxaphosphocin
acetic acid 5-[3-(4-acetoxypyrrolidin-2-ylmethyl)-6,6’-difluoro-1H,1H-[2,2]biindolyl-3-ylmethyl]pyrrolidin-3-yl ester
C30H32F2N4O4 (550.2391495999999)
Manumycin A
C31H38N2O7 (550.2678877999999)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
methyl (1beta,11beta,12alpha,15beta)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-1,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicrasan-21-oate
Glu-Phe-Gln-Gln
A tetrapeptide composed of L-glutamic acid, L-phenylalanine and two L-glutamine units joined by peptide linkages.
3,15-di-O-propionylbruceolide
A quassinoid that is the 3,15-di-O-propionyl derivative of bruceolide. It has been isolated from Brucea javanica and Brucea sumatrana.
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
(R)-2,4,6-Trimethyl-deca-2,4-dienoic acid {(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-6-(2-hydroxy-5-oxo-cyclopent-1-enylcarbamoyl)-hexa-1,3,5-trienyl]-2-oxo-7-oxa-bicyclo[4.1.0]hept-3-en-3-yl}-amide
C31H38N2O7 (550.2678877999999)
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea
1-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea
1-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
N-[(2R,3R)-2-[[[(4-fluoroanilino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
C28H31FN6O5 (550.2339847999999)
N-[(2S,3S)-2-[[[(4-fluoroanilino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
C28H31FN6O5 (550.2339847999999)
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
1-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
1-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea
N-[(2S,3R)-2-[[[(4-fluoroanilino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
C28H31FN6O5 (550.2339847999999)
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(3-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
(2E,4E,6R)-N-[(5S,6R)-5-[(1E,3E,5E)-7-[(2,5-dioxocyclopentyl)amino]-7-oxohepta-1,3,5-trienyl]-5-hydroxy-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienamide
C31H38N2O7 (550.2678877999999)
6-[(10-Butanoyl-3-hydroxy-2,2-dimethyl-8-oxo-6-propyl-3,4-dihydropyrano[3,2-g]chromen-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2S)-2-[[(2S)-2-[(1-ethoxycarbonylpiperidin-4-yl)oxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
bruceanol E
A quassinoid that is the dihydro derivative of bruceanol D. Isolated from Brucea antidysenterica, it exhibits in vitro cytotoxicity towards several human tumour cell lines.
Pluripotin
Pluripotin is a dual inhibitor of ERK1 and RasGAP with KDs of 98 nM and 212 nM, respectively. Pluripotin also inhibits RSK1, RSK2, RSK3, and RSK4 with IC50s of 0.5, 2.5, 3.3, and 10.0 μM, respectively.
SOS1-IN-14
SOS1-IN-14 is a potent, selective and orally active SOS1 inhibitor with an IC50 value of 3.9 nM. SOS1-IN-14 can be absorbed in the intestine via a P-glycoprotein-mediated efflux mechanism. SOS1-IN-14 can be used to research KRAS-mutated cancers. SOS1-IN-14 has better potent tumor suppression than BI-3406 (HY-125817)[1].
(9ar,11as)-1-{2-hydroxy-1-[5-(methoxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthrene-7-sulfonic acid
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 5-[7-(acetyloxy)-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{4-[(2s,3r)-3-(hydroxymethyl)-5-[(1e)-3-hydroxyprop-1-en-1-yl]-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2,6-dimethoxyphenoxy}oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{4-[(1r,3as,4r,6as)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 5-(acetyloxy)-4-{[2,3-bis(acetyloxy)-2-methylbutanoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(3r,4r)-4-{[(2s,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]methyl}-3-[(4-hydroxy-3-methoxyphenyl)methyl]-4-methyloxolan-2-one
2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
[(1s,2s,3s,4r,7s,8e,12s,13s,14r)-2,12,14-tris(acetyloxy)-3-hydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-9-yl]methyl acetate
(9r,13s,16s,17r,18s)-16-[(1r)-1-hydroxy-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-8,8,13,17-tetramethyl-6,15-dioxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4,10-tetraen-18-yl acetate
2-{4-[4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2e,4e,6r)-n-[(1s,5s,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid
C31H38N2O7 (550.2678877999999)
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{4-[(2s,3r)-3-(hydroxymethyl)-5-[(1e)-3-hydroxyprop-1-en-1-yl]-4-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2,6-dimethoxyphenoxy}oxane-3,4,5-triol
methyl (4r,5r,6s)-6-(2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}ethyl)-5-ethenyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-1-ene-1-carboxylate
(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadeca-9,11-dien-14-yl (2z)-2-methylbut-2-enoate
methyl (3as,4s,5s,11ar)-4-{[(2s,3r)-3-(acetyloxy)-2-hydroxy-2-methylbutanoyl]oxy}-10-methyl-5-{[(2s)-2-methylbutanoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
alpinnanin a
{"Ingredient_id": "HBIN015752","Ingredient_name": "alpinnanin a","Alias": "NA","Ingredient_formula": "C35H34O6","Ingredient_Smile": "COC1=C(C(=C(C(=C1)O)C(C=CCC(CCC2=CC=CC=C2)O)C3=CC=C(C=C3)O)O)C(=O)C=CC4=CC=CC=C4","Ingredient_weight": "550.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "986","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11613685","DrugBank_id": "NA"}
alpinnanin c
{"Ingredient_id": "HBIN015754","Ingredient_name": "alpinnanin c","Alias": "NA","Ingredient_formula": "C35H34O6","Ingredient_Smile": "COC1=C(C(=C(C(=C1)O)C(CC(CCC2=CC=CC=C2)O)C=CC3=CC=C(C=C3)O)O)C(=O)C=CC4=CC=CC=C4","Ingredient_weight": "550.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "988","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11678391","DrugBank_id": "NA"}
(2r,3r,4s,5s,6r)-2-{[2-(4-hydroxy-3,5-dimethoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-1-benzofuran-3-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (3as,4s,5s,11ar)-5-(acetyloxy)-4-{[(2s,3s)-2,3-bis(acetyloxy)-2-methylbutanoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
10'-hydroxy-1',6,6',9,10'-pentamethyl-2,5',7-trioxo-4,5,9a,9b-tetrahydro-3ah-4'-oxaspiro[azuleno[4,5-b]furan-3,14'-tetracyclo[10.2.1.0²,¹¹.0³,⁷]pentadecan]-2'(11')-en-8'-yl acetate
[(1s,2s,3e,7r,8z,10r,13s)-9,10,13-tris(acetyloxy)-2,7-dihydroxy-8,12,15,15-tetramethyl-5-oxobicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate
2,5,7-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-9-yl acetate
(1s,2r,5r,6s,7s,8r,9r,12r)-12-(acetyloxy)-7-(benzoyloxy)-5-hydroxy-2,6,10,10-tetramethyl-4-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate
methyl 2-(furan-3-yl)-6a,10b-dimethyl-4,9-dioxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
(1r,2s,4r,5r,6r,7r,9s)-4-(acetyloxy)-5-(benzoyloxy)-2-hydroxy-2,6,10,10-tetramethyl-12-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
(2s,3r,4s,5r,6r)-2-{4-[(1s,3ar,4s,6ar)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
1-{2,4-dihydroxy-3-[5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-1-en-3-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one
[(1s,2s,3r,4r,7s,8e,12s,13r,14s)-2,12,14-tris(acetyloxy)-3-hydroxy-4,13-dimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-9-yl]methyl acetate
methyl (2s,6r,6ar,9r,10as,10bs)-2-(furan-3-yl)-9-hydroxy-6a,10b-dimethyl-4-oxo-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
5,5-dimethyl-4-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one
(2e)-1-{2,4-dihydroxy-3-[(2e)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-2-en-1-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one
(1s,2r,3s,4r,7s,8z,10r,12r,13r,14s)-10,12,14-tris(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-2-yl acetate
(1s,2r,3r,4r,7s,8z,10r,12s,13r,14s)-10,12,14-tris(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-2-yl acetate
[(1s,4s,5s,6r,9s,10r,11r,12r,14r)-5,6-dihydroxy-7-(hydroxymethyl)-3,11,14-trimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate
(1r,2s,3r,4r,7s,8z,10r,12s,13s,14s)-2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
2,5,10-tris(acetyloxy)-7-hydroxy-4,14,16,16-tetramethyl-8-methylidene-13-oxo-15-oxatetracyclo[9.4.1.0¹,¹⁴.0⁴,⁹]hexadecan-3-yl acetate
(2s)-2-methyl-1-[9,12,14-trihydroxy-13-(2-hydroxy-3-methylbut-3-en-1-yl)-5,5-dimethyl-8-[(2s)-2-methylbutanoyl]-6,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,8,11(16),12,14-heptaen-15-yl]butan-1-one
(1s,2s,3s,4r,7s,8z,12s,13s,14r,15s)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
(3s)-4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]oxolan-2-one
(4s,7s,18s,21s)-3,9,17,23-tetrahydroxy-4,5,7,18,19,21-hexamethyl-2,5,8,16,19,22-hexaazatricyclo[22.4.0.0¹⁰,¹⁵]octacosa-1(28),2,8,10,12,14,16,22,24,26-decaene-6,20-dione
C28H34N6O6 (550.2539704000001)
2-{[2-(4-hydroxy-3,5-dimethoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-1-benzofuran-3-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(4r)-3-(hydroxymethyl)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one
[(1s,2s,3r,6s,8r,9r,10r,11r,12s,13r)-8-acetyl-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-11,12-dihydroxy-13-(methoxycarbonyl)-9-methyl-4-oxo-14-oxatetracyclo[8.5.0.0¹,⁶.0²,¹³]pentadecan-9-yl]acetic acid
[(1s,4s,5r,6r,9s,10r,11r,12r,14r)-4,5,6-trihydroxy-3,11,14-trimethyl-7-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate
(1s,2s,3r,4r,7s,8z,12s,13s,14r,15s)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
methyl 4-{[3-(acetyloxy)-2-hydroxy-2-methylbutanoyl]oxy}-10-methyl-5-[(2-methylbutanoyl)oxy]-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(1s,4r,11r,14s,17s,20r)-4-[(2s)-butan-2-yl]-14-[(1r)-1-hydroxyethyl]-17-isopropyl-11,20-dimethyl-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-2,5(22),7,9,12,15,18(21)-heptaene-2,9,12,15-tetrol
C25H38N6O6S (550.2573408000001)
(2e)-1-{2,4-dihydroxy-3-[(1s,2e,5r)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-2-en-1-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one
4-hydroxy-3,5,5-trimethyl-4-(3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl)cyclohex-2-en-1-one
(1s,2s,3r,5r,8s,9z,11r,13s,14r,15s,17s,19r)-11,15-bis(acetyloxy)-2-hydroxy-5,10,14,19-tetramethyl-6-oxo-4,7,18-trioxapentacyclo[12.5.0.0³,⁵.0³,⁸.0¹⁷,¹⁹]nonadec-9-en-13-yl butanoate
(1s,2s,4s,7r,8r,9s,10s,12s,13s,16r)-7,8,10-tris(acetyloxy)-12,13-dihydroxy-5,9-dimethyl-2-(prop-1-en-2-yl)-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-5-en-4-yl acetate
2-(hydroxymethyl)-6-{[1,5,5-trimethyl-6-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl)-7-oxabicyclo[4.1.0]heptan-3-yl]oxy}oxane-3,4,5-triol
(1s,2s,3r,4r,7s,8z,10r,12s,13r,14s)-2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
methyl (1r,2s,3r,6r,8s,9r,11s,13s,14s,15r,16s,17s)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-11,15,16-trihydroxy-9,13-dimethyl-4,12-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadecane-17-carboxylate
(1s,2r,3s,4r,5s,7s,8s,9s,12z,14s,17r)-2,5,7-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-9-yl acetate
(1r,2r,3r,4s,7r,8z,12r,13r,14s,15r)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
9,13,15-tris(acetyloxy)-14-hydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15h,15ah-cyclotetradeca[b]furan-4-yl acetate
2-[4,8-bis(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl acetate
methyl (1r,2s,6r,8s,9r,13s,14s,15r)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-11,15,16-trihydroxy-9,13-dimethyl-4,12-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadecane-17-carboxylate
(1s,2r,3s,4r,7s,8z,10r,12r,13r,14s)-10,12,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate
3,9,17,23-tetrahydroxy-4,5,7,18,19,21-hexamethyl-2,5,8,16,19,22-hexaazatricyclo[22.4.0.0¹⁰,¹⁵]octacosa-1(28),2,8,10,12,14,16,22,24,26-decaene-6,20-dione
C28H34N6O6 (550.2539704000001)
(2e)-1-{2,4-dihydroxy-3-[(1e,3r,5s)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-1-en-3-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one
2-(acetyloxy)-1-[7,14-bis(acetyloxy)-7-methyl-2-methylidene-5,13-dioxatricyclo[8.4.0.0⁴,⁶]tetradec-11-en-11-yl]-2-(3,3-dimethyloxiran-2-yl)ethyl acetate
(1r,2r,3r,4s,7r,8z,12r,13r,14r,16s)-2,14,16-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
(1r,2s,3r,4s,5s,7s,9r,10r,11r,14s)-2,5,10-tris(acetyloxy)-7-hydroxy-4,14,16,16-tetramethyl-8-methylidene-13-oxo-15-oxatetracyclo[9.4.1.0¹,¹⁴.0⁴,⁹]hexadecan-3-yl acetate
2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-12-yl acetate
(1s,2s,3s,4r,5s,7s,8s,9r,12z,14s,17r)-5,7,9-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-2-yl acetate
(1r,2r)-2-(acetyloxy)-1-[(1r,4r,6r,7s,10s,14r)-7,14-bis(acetyloxy)-7-methyl-2-methylidene-5,13-dioxatricyclo[8.4.0.0⁴,⁶]tetradec-11-en-11-yl]-2-[(2r)-3,3-dimethyloxiran-2-yl]ethyl acetate
[2,12,14-tris(acetyloxy)-3-hydroxy-4,13-dimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-9-yl]methyl acetate
(1s,2s,3r,5r,8s,9z,12r,13r,14r,15s,17s,19r)-12,15-bis(acetyloxy)-2-hydroxy-5,10,14,19-tetramethyl-6-oxo-4,7,18-trioxapentacyclo[12.5.0.0³,⁵.0³,⁸.0¹⁷,¹⁹]nonadec-9-en-13-yl butanoate
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,3s,6s)-1,5,5-trimethyl-6-[(1e,3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]-7-oxabicyclo[4.1.0]heptan-3-yl]oxy}oxane-3,4,5-triol
(1s,2r,3s,4r,5s,7s,8s,9r,12z,14s,17r)-5,7,9-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-2-yl acetate
(3ar,4r,9s,13r,14s,15s,15as)-4,9,13-tris(acetyloxy)-14-hydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15h,15ah-cyclotetradeca[b]furan-15-yl acetate
20-methoxy-7,23,33-trioxa-15,30-diazaoctacyclo[19.9.3.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁴,³².0²⁷,³¹.0²²,³⁴]heptatriaconta-3,5,8(35),9,11,18(34),19,21,24(32),25,27(31),36-dodecaene-9,25-diol
12-(acetyloxy)-7-(benzoyloxy)-5-hydroxy-2,6,10,10-tetramethyl-4-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate
[(1r,2s,3e,7r,8e,10r,13s)-9,10,13-tris(acetyloxy)-2,7-dihydroxy-8,12,15,15-tetramethyl-5-oxobicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate
(1r,2r,3s,4r,5s,7s,8s,9r,12z,14s,17r)-5,7,9-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-2-yl acetate
(4,5,6-trihydroxy-3,11,14-trimethyl-7-{[(2-methylbut-2-enoyl)oxy]methyl}-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl)methyl benzoate
[(1r,2s,3z,7r,8e,10r,13s)-9,10,13-tris(acetyloxy)-2,7-dihydroxy-8,12,15,15-tetramethyl-5-oxobicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate
methyl (3as,4s,5s,11ar)-4-{[(2s,3s)-3-(acetyloxy)-2-hydroxy-2-methylbutanoyl]oxy}-10-methyl-5-{[(2r)-2-methylbutanoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
2,14,16-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
methyl (2r,3r,6r,8s,9r,12s,13s,14s,15r,16r,17r)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-12,15,16-trihydroxy-9,13-dimethyl-4,11-dioxo-5,19-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadecane-17-carboxylate
16-[1-hydroxy-1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-8,8,13,17-tetramethyl-6,15-dioxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4,10-tetraen-18-yl acetate
(1's,3r,3's,3as,6's,7'r,8's,9as,9bs,10'r,12's)-10'-hydroxy-1',6,6',9,10'-pentamethyl-2,5',7-trioxo-4,5,9a,9b-tetrahydro-3ah-4'-oxaspiro[azuleno[4,5-b]furan-3,14'-tetracyclo[10.2.1.0²,¹¹.0³,⁷]pentadecan]-2'(11')-en-8'-yl acetate
1-{2,4-dihydroxy-3-[5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-2-en-1-yl]-6-methoxyphenyl}-3-phenylprop-2-en-1-one
4-{[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]methyl}-3-[(4-hydroxy-3-methoxyphenyl)methyl]-4-methyloxolan-2-one
14-(1-hydroxyethyl)-17-isopropyl-11,20-dimethyl-4-(sec-butyl)-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-2,5(22),7,9,12,15,18(21)-heptaene-2,9,12,15-tetrol
C25H38N6O6S (550.2573408000001)
3-(hydroxymethyl)-5,5-dimethyl-4-(3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl)cyclohex-2-en-1-one
(1s,2s,7r,8r,9s,10s,12s,13s,16r)-7,8,10-tris(acetyloxy)-12,13-dihydroxy-5,9-dimethyl-2-(prop-1-en-2-yl)-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-4-en-4-yl acetate
7,8,10-tris(acetyloxy)-12,13-dihydroxy-5,9-dimethyl-2-(prop-1-en-2-yl)-15-oxatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadec-5-en-4-yl acetate
(4s)-4-hydroxy-3,5,5-trimethyl-4-[(3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one
2,9-bis(acetyloxy)-4,5-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-6,12-dien-11-yl butanoate
[9,10,13-tris(acetyloxy)-2,7-dihydroxy-8,12,15,15-tetramethyl-5-oxobicyclo[9.3.1]pentadeca-3,8,11-trien-4-yl]methyl acetate
(4s)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one
3-{2,5-dihydroxy-4-[2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]-3,6-dioxocyclohexa-1,4-dien-1-yl}-2-(3-methylbut-2-en-1-yl)-1h-indole-7-carboxylic acid
4-(acetyloxy)-5-(benzoyloxy)-2-hydroxy-2,6,10,10-tetramethyl-12-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
(2e,4e,6r)-n-[(1s,5r,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid
C31H38N2O7 (550.2678877999999)
n-[(1r,5s,6r)-5-hydroxy-5-{6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid
C31H38N2O7 (550.2678877999999)